SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Marta B. Lopes, Geisa A. L. Gonçalves, Daniel Felício-Silva, Kristala L. J. Prather, Gabriel A. Monteiro, Duarte M. F. Prazeres, Cecília R. C. Calado, In situNIR spectroscopy monitoring of plasmid production processes: effect of producing strain, medium composition and the cultivation strategy, Journal of Chemical Technology and Biotechnology, 2015, 90, 2
  2. 2
    Alvaro San Millan, Macarena Toll-Riera, Qin Qi, R. Craig MacLean, Interactions between horizontally acquired genes create a fitness cost in Pseudomonas aeruginosa, Nature Communications, 2015, 6, 6845

    CrossRef

  3. 3
    M.E. Monteiro, L. Raiado-Pereira, D.M.F. Prazeres, M. Mateus, Preparation of liposome membrane adsorbers and testing for plasmid purification, Biochemical Engineering Journal, 2015, 93, 1

    CrossRef

  4. 4
    Geisa A.L. Gonçalves, Kristala L.J. Prather, Gabriel A. Monteiro, Duarte M.F. Prazeres, Engineering of Escherichia coli strains for plasmid biopharmaceutical production: Scale-up challenges, Vaccine, 2014, 32, 24, 2847

    CrossRef

  5. 5
    Vítor M. Gaspar, Cláudio J. Maia, João A. Queiroz, Chantal Pichon, Ilídio J. Correia, Fani Sousa, Improved Minicircle DNA Biosynthesis for Gene Therapy Applications, Human Gene Therapy Methods, 2014, 25, 2, 93

    CrossRef

  6. 6
    Geisa A.L. Gonçalves, Kristala L.J. Prather, Gabriel A. Monteiro, Aaron E. Carnes, Duarte M.F. Prazeres, Plasmid DNA production with Escherichia coli GALG20, a pgi-gene knockout strain: Fermentation strategies and impact on downstream processing, Journal of Biotechnology, 2014, 186, 119

    CrossRef

  7. 7
    Alex Xenopoulos, Priyabrata Pattnaik, Production and purification of plasmid DNA vaccines: is there scope for further innovation?, Expert Review of Vaccines, 2014, 13, 12, 1537

    CrossRef

  8. 8
    Aleš Berlec, Borut Štrukelj, Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells, Journal of Industrial Microbiology & Biotechnology, 2013, 40, 3-4, 257

    CrossRef

  9. 9
    Geisa A. L. Gonçalves, Duarte M. F. Prazeres, Gabriel A. Monteiro, Kristala L. J. Prather, De novo creation of MG1655-derived E. coli strains specifically designed for plasmid DNA production, Applied Microbiology and Biotechnology, 2013, 97, 2, 611

    CrossRef

  10. 10
    David A. Baltrus, Exploring the costs of horizontal gene transfer, Trends in Ecology & Evolution, 2013, 28, 8, 489

    CrossRef

  11. 11
    Anne Luise Tscheliessnig, Julita Konrath, Ron Bates, Alois Jungbauer, Host cell protein analysis in therapeutic protein bioprocessing – methods and applications, Biotechnology Journal, 2013, 8, 6
  12. 12
    James Williams, Vector Design for Improved DNA Vaccine Efficacy, Safety and Production, Vaccines, 2013, 1, 3, 225

    CrossRef

  13. You have free access to this content13
    Sang Yup Lee, Editorial: State-of-the-art reviews in industrial biotechnology, Biotechnology Journal, 2012, 7, 2
  14. 14
    Gheorghe M Borja, Eugenio Meza Mora, Blanca Barrón, Guillermo Gosset, Octavio T Ramírez, Alvaro R Lara, Engineering Escherichia coli to increase plasmid DNA production in high cell-density cultivations in batch mode, Microbial Cell Factories, 2012, 11, 1, 132

    CrossRef

  15. 15
    Jimena A. Ruiz, Alejandra de Almeida, Manuel S. Godoy, Mariela P. Mezzina, Gonzalo N. Bidart, Beatriz S. Méndez, M. Julia Pettinari, Pablo I. Nikel, ESCHERICHIA COLI REDOX MUTANTS AS MICROBIAL CELL FACTORIES FOR THE SYNTHESIS OF REDUCED BIOCHEMICALS, Computational and Structural Biotechnology Journal, 2012, 3, 4, 1

    CrossRef

  16. 16
    A. Gabriela Gomes, Ana M. Azevedo, M. Raquel Aires-Barros, D. Miguel F. Prazeres, Validation and scale-up of plasmid DNA purification by phenyl-boronic acid chromatography, Journal of Separation Science, 2012, 35, 22